On April 29th，Boston Chinese Investment Club (BCIC) successfully held the 2nd international biotech start-up pitch competition. Since the beginning of 2023, the international biotech start-up pitch competition sponsored by BCIC has gradually unfolded. The purpose of the competition is to explore early-stage biotech projects with high quality and potential in North America and other regions, to accelerate the transfer and transformation of scientific and technological achievements, and to promote effective communication between startups and investors.
In this competition, excellent teams from 86 biotech-related startups from around the world participated. After several exciting rounds of competition, a total of 16 teams made it to the final. Let us first congratulate the winning teams:
First Place：
Myro Therapeutics develops first-class small molecule therapies by studying the mechanisms of central nervous system diseases.
Second Place：
InGel Therapeutics INC, a Harvard spin-off company, develops cell-based therapies for patients who have lost their vision due to retinal degeneration. Their initial target indication is pigmentary retinopathy, with plans to expand to dry age-related macular degeneration and glaucoma.
Second Place：
Full Circles Therapeutics uses an innovative genome engineering solution with a knock-in/knock-out non-viral gene writing platform to discover, develop, and manufacture new therapeutic genome drugs.
Third Place：
Third Place: Neodroid Biosciences is a startup company developing next-generation nanomedicine. To address key biopharmaceutical challenges, they have developed PromoRNA for enhancing cancer immunotherapy; PromoDNA for organ-defined diseases; CytoDirect for cell-specific direct delivery to the cytosol; and Synbody for multi-valent, multi-functional targeting
Third Place：
Elpis Biopharmaceuticals is a clinical-stage biotech company based in Boston. Elpis is developing multi-module homologous gamma/delta CAR-T and CAR-NK therapies to provide durable anti-tumor activity for the treatment of solid tumors and other types of cancer.
Third Place：
DoriVac is a preclinical biotech startup that develops cancer immunotherapy using DNA nanotechnology. DoriVac offers a personalized cancer vaccine platform that uses DNA origami technology to control the spacing and geometry of co-presented tumor antigens and adjuvant ligands with nanometer precision.
Innovation award winners:
-Dart Biosciences,
-Likarda, LLC
-FuseBio
-CartaBio
-Aplife Biotech,
-Adcura, Inc
-SunVax mRNA Therapeutics, Inc.
-Great Bay Bio
-Santolecan Pharmaceuticals LLC
-Cellula BioPharma, Inc
-Elpis Biopharmaceuticals
-511 Therapeutics Inc
This competition would not have been possible without the strong support and sponsorship from Shanghai Zhangjiang Science City, Hong Kong Science and Technology Park, Suzhou Jinji Lake Science and Technology Park, Medisun, Pudao Capital, Xingu Chuangfu, Viya Biomedical, ATLATL, Chaosheng Innovation Laboratory, AAEA, Boston Chinese Investment Club (BCIC), Wuming Capital, Xing Yuan Zhi Tong, AMFA, WELINK, EY, and QBay, as well as the long-term support from our sponsor, E Fund Management Co., Ltd. We also thank all our partners and the live stream supporters, E Pharm Manager, Shenlan Guan, CyberBlue, Hicool, and the thousands of online viewers. Special thanks to Ms. Wang Chen, founder of Shenlan Guan, for her Chinese translation and publicity efforts, which helped more people to learn about our event. We would also like to thank all the staff and volunteers of BCIC for their hard work and contributions in organizing this event over the past few months. Your efforts have been key to our success.
We welcome all organizations to support, sponsor, and collaborate with us. BCIC, formerly known as the Boston Chapter of the Chinese Finance Association of North America, is committed to promoting exchanges and discussions in Chinese finance and investment, building a platform for connecting Chinese and American capital and projects, providing investment opportunities, professional and social services to our members, and actively contributing to the talent and advice of China’s investment and financial industry. We have branches and offices in New York, Washington, Beijing, Shanghai, Chengdu, and Shenzhen, with over 6,000 members widely distributed around the world.
Through this competition, we have seen excellent projects and entrepreneurial teams from all over the world and have built a platform for exchanges and cooperation in the field of biomedicine entrepreneurship. Secondly, this competition has injected new vitality and impetus into the innovation and development of the biomedicine industry, and is expected to promote the rapid development and transformation of the industry. Finally, this competition has also promoted international exchanges and cooperation, making positive contributions to the common prosperity and development of the global biomedicine industry. We believe that in the future, the impact of this competition will continue to expand and extend, injecting continuous energy and vitality into the long-term development and prosperity of the biomedicine industry. A for-profit entity AlphaBio Ventures LLC was set up to facilitate global outstanding healthcare startups in funding raising and expanding across USA and Asia market.
Harvard Medical School Professor Wagner
Organizers
【BCIC Sponsors】
E Fund Management Co., LTD.
U.S. & International Tax and Legal Services
Shanghai Zhangjiang Boston Enterprise Park
(http://www.zjbostonpark.com/)
Global Asset Management
(https://www.haitouglobal.com/)
Dolphin Capital
JJLake Asian Future Innovation Challenge Boston Chapter
Hong Kong Science Technology Park
(https://bcicglobal.org/sponsors/)
Start Point Advisors/行远致同
Financial Advisors for Healthcare Startups
Early stage capital for startups in Healthcare and Consumption
Boston Chinese Investment Club (BCIC) is a non-profit organization founded in 2010 with more 6000 professionals in Finance, Venture Capital, and various technology industries. It serves as a Boston centered platform for exchanging ideas, knowledge, and information in finance and related areas between US and China. Main activities include summits, conferences, and seminars. （https://bcicglobal.org/）
